Exavir Therapeutics
Jeff brings almost 30 years of drug development and regulatory experience to Exavir from US FDA, where he was most recently Deputy Director of the Division of Antivirals. Jeff was the author/co-author for 10 Guidance Documents for Industry addressing HIV, HBV, HCV, HDV, Influenza, PEPFAR, CMV, RSV.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Exavir Therapeutics
Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections.